Articles published by Hemogenyx Pharmaceuticals PLC
Hemogenyx Pharmaceuticals PLC Announces Investor Webinar
June 27, 2022
Via AccessWire
Hemogenyx Pharmaceuticals PLC Announces CBR Update
March 16, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via AccessWire
Hemogenyx Pharmaceuticals Partnership with Selexis
January 12, 2022
Via AccessWire
Via AccessWire
Via AccessWire
Exposures
Product Safety
Hemogenyx Pharmaceuticals PLC Announces Convertible Loans Repayment
November 24, 2021
Via AccessWire
Hemogenyx Pharmaceuticals Announces CDX Licence Agreement
October 13, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Half-Year Report
September 30, 2021
Via AccessWire
Topics
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces U.S. Approval of Monoclonal Antibody Patent
September 02, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via AccessWire
Exposures
COVID-19
Hemogenyx Pharmaceuticals PLC Announces
June 02, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via AccessWire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.